This promotes lipolysis and fatty acid oxidation while suppressing PPARγ, collectively contributing to a pronounced anti-obesity effect (Zheng M. et al., 2024; Zheng W. et al., 2024; Nohesara et al., 2025). The gene discussed is PPARG; the disease is obesity disorder.